According to SCYNEXIS's latest financial reports the company's total liabilities are $55.45 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $84.57 M | 7.63% |
2021-12-31 | $78.57 M | -1.5% |
2020-12-31 | $79.77 M | 80.26% |
2019-12-31 | $44.25 M | 101.68% |
2018-12-31 | $21.94 M | -10.21% |
2017-12-31 | $24.44 M | -2.13% |
2016-12-31 | $24.97 M | 240.97% |
2015-12-31 | $7.32 M | 17.35% |
2014-12-31 | $6.24 M | -81.28% |
2013-12-31 | $33.33 M | 6.02% |
2012-12-31 | $31.44 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Galmed Pharmaceuticals
GLMD | $2.75 M | -95.04% | ๐ฎ๐ฑ Israel |
Catalyst Pharmaceuticals CPRX | $82.23 M | 48.30% | ๐บ๐ธ USA |
Catalent CTLT | $6.30 B | 11,263.39% | ๐บ๐ธ USA |
KemPharm KMPH | $29.72 M | -46.40% | ๐บ๐ธ USA |